GlaxoSmithKline PLC Director/PDMR Shareholding (2908U)

TIDMGSK

RNS Number : 2908U

GlaxoSmithKline PLC

16 January 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ========================================================================= 
 a)   Name                     Dr M M Slaoui 
===  ========================  =============================================== 
 b)   Position/status          Chairman, Global Vaccines 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           American Depositary Shares ('ADSs') 
       the financial            ISIN: US37733W1053 
       instrument 
===  ========================  =============================================== 
 b)   Nature of the            Acquisition of ADSs following the re-investment 
       transaction              of dividends paid to shareholders on 12 
                                January 2017 on ADSs held in the Company's 
                                US Deferred Performance Plan. 
===  ========================  =============================================== 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                 ---------  ---------- 
                                  $39.01     266.485 
                                 ---------  ---------- 
===  ========================  =============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =============================================== 
 e)   Date of the transaction  2017-01-12 
===  ========================  =============================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ========================================================================= 
 a)   Name                     Mr D E Troy 
===  ========================  =============================================== 
 b)   Position/status          SVP & General Counsel 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           American Depositary Shares ('ADSs') 
       the financial            ISIN: US37733W1053 
       instrument 
===  ========================  =============================================== 
 b)   Nature of the            Acquisition of ADSs following the re-investment 
       transaction              of dividends paid to shareholders on 12 
                                January 2017 on ADSs held in the Company's 
                                US Deferred Performance Share Plan. 
===  ========================  =============================================== 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                 ---------  ---------- 
                                  $39.01     353.083 
                                 ---------  ---------- 
                                  $39.01     5.441 
                                 ---------  ---------- 
===  ========================  =============================================== 
 d)   Aggregated information 
       Aggregated volume 
        Price 
                                 358.524 
                                 $39.01 
===  ========================  =============================================== 
 e)   Date of the transaction  2017-01-12 
===  ========================  =============================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  =============================================== 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDQLFFDFFBBBF

(END) Dow Jones Newswires

January 16, 2017 12:04 ET (17:04 GMT)